How has been the historical performance of the Omkar Pharmachem?

Answer:The historical performance of Omkar Pharmachem shows a consistent pattern of minimal financial activity over the years, with net sales remaining at zero from March 2018 through March 2025. The total operating income has been stable at Rs 0.54 crore for the last three years, with a slight increase from Rs 0.27 crore in March 2021. The company has reported operating profits (PBDIT) that have fluctuated slightly, peaking at Rs 0.31 crore in March 2023, and showing a modest profit of Rs 0.29 crore in March 2025. Profit before tax has also shown a gradual improvement, reaching Rs 0.27 crore in March 2025, while profit after tax has remained relatively stable, with Rs 0.20 crore reported in March 2025. Breakdown: Omkar Pharmachem's financial results indicate a long-standing lack of sales activity, with net sales consistently recorded at zero from March 2018 to March 2025. The company has, however, seen a gradual increase in other operating income, which rose from Rs 0.27 crore in March 2021 to Rs 0.54 crore in the subsequent years. Operating profits have shown slight fluctuations, with a peak of Rs 0.31 crore in March 2023, followed by Rs 0.29 crore in March 2025. Profit before tax has improved over the years, culminating in Rs 0.27 crore in March 2025, while profit after tax has remained stable around Rs 0.20 crore during the last three reporting periods. The balance sheet reflects a total liability of Rs 9.49 crore as of March 2024, with total assets slightly declining to Rs 9.49 crore, indicating a stable but stagnant financial position. Cash flow statements indicate no cash inflow or outflow across the years, highlighting a lack of operational activity.